|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's range||264.78 - 277.87|
|52-week range||223.25 - 468.55|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||21.32|
|Earnings date||20 Oct 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||392.37|
Yahoo Finance's Brian Sozzi, Brian Cheung and Julie Hyman break down how Novavax, Biogen, and Abbott Labs are faring in Wednesday’s market
Image source: The Motley Fool. Biogen inc (NASDAQ: BIIB)Q3 2021 Earnings CallOct 20, 2021, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning.
Regulatory and pipeline updates from bigwigs like Regeneron (REGN) and Biogen (BIIB) have been the biotech sector's few key highlights during the past week.